InDevR and Sino Biological team up to deliver multiplexed analytical solutions for mRNA vaccine and cell & gene therapy

FHS
June 7, 2024
4:57 am

InDevR, Inc., a leader in analytical solutions for vaccine in-process and quality control testing, and Sino Biological, Inc., a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext specializing in biological research reagents and related technical contract research services, today announced a new partnership to speed development of multiplexed assays for a broad range of vaccine, mRNA therapies and cell and gene therapy applications.

Unveiling the Mysteries of the Mind: A Landmark Event in New Orleans | Psychedelic Invest

This gathering promises to be a melting pot of ideas, showcasing the latest advancements and innovative research in psychology. Whether you’re a seasoned professional, an

February 14, 2024

Health System Eliminates Noncompetes for Primary Care Physicians

Indiana University (IU) Health will eliminate noncompete clauses for its primary care physicians in a new policy effective December 15. The move will affect nearly

June 18, 2024

Why Are Docs Still on X? Oral Allergy Syndrome PSA; Looking for a Girl in Healthcare

The following contains links to social media websites including X, TikTok, Instagram, Facebook, and LinkedIn. Arghavan Salles, MD, PhD, polled her audience on X: why

May 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.